Abstract
515 - How Cost Affects the Treatment Choice for Irritable Bowel Syndrome with Diarrhea Patients: A Cost-Effectiveness Analysis of Tricyclic Agents and Rifaximin
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
